TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,934
|
5,437
|
4,828 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
347
|
575
|
654 |
| EBITDA |
362
|
577
|
676 |
| Total assets |
1,247
|
1,400
|
1,803 |
| Current assets |
1,115
|
1,247
|
1,739 |
| Current liabilities |
785
|
937
|
1,365 |
| Equity capital |
462
|
463
|
438 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
14
|
14
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
37.0%
|
33.1%
|
24.3% |
| Turnover per employee |
352
|
388
|
371 |
| Profit as a percentage of turnover |
7.0%
|
10.6%
|
13.5% |
| Return on assets (ROA) |
27.8%
|
41.1%
|
36.3% |
| Current ratio |
142.0%
|
133.1%
|
127.4% |
| Return on equity (ROE) |
75.1%
|
124.2%
|
149.3% |
| Change turnover |
-318
|
595
|
-300 |
| Change turnover % |
-6%
|
12%
|
-6% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
8%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.